The Effects of Plant Bioactives on Platelet Function

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-06-30

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Consumption of a diet rich in fruit and vegetables is associated with a reduced risk of cardiovascular disease and the protective effect may be due to polyphenolic compounds contained within these foods. The mechanism by which polyphenols exert this effect is not clearly understood but research has focused on their potential to affect platelet function. The purpose of this study is to quantify the anti-clotting activity of a range of plant food extracts and component compounds.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Flavonoids, Blood Pressure and Blood Vessel Function

NCT01530893

Cardiovascular Disease Risk Reduction

COMPLETED NA

In Vitro and in Vivo Evaluation of the Anti-Inflammatory and Antithrombotic Synergy of Vitamin C and Bioflavonoids in Healthy Subjects

NCT07061431

Cardio-protection

COMPLETED NA

Effect of a Polyphenol Rich Diet on Vascular and Platelet Function

NCT01319786

Hypertension

COMPLETED NA

Effects of Flavonoids on Cognitive Performance in Healthy Young Adults

NCT01312597

Neurodegeneration

COMPLETED PHASE2

The Effects of Aronia Juice Polyphenols on Cardiovascular Disease Risk

NCT02800967

Hypertension Overweight

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A single sample of whole blood will be collected from 15 male or female volunteers aged between 18 and 65 years. After collection whole blood will be treated with a range of flavonoids to evaluate their effects on platelet function.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ex-vivo treatment of platelets

Group Type EXPERIMENTAL

Ex-vivo treatments with flavonoids

Intervention Type OTHER

Ex-vivo treatment of platelets with a range of flavonoids

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ex-vivo treatments with flavonoids

Ex-vivo treatment of platelets with a range of flavonoids

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males and females
* Aged 18 - 65 years.
* BMI \> 19.5 and \< 35
* Non-smokers

Exclusion Criteria

* Pregnancy or have been pregnant within the last 12 months
* Parallel participation in another research project which involves dietary intervention
* Participation in another research project which has involved blood sampling within the last four months unless the total amount of combined blood from both studies does not exceed 470 mls.
* Has donated or intends to donate blood within 16 weeks prior to during the Study period.
* Depressed or elevated blood pressure measurements (\<90/50 or 95/50 if symptomatic or \>160/100)
* Any person related to or living with any member of the study team
* Diabetics
* Taking regular prescribed and/or non-prescribed medication (excluding oral contraceptive and HRT).
* Known bleeding disorders.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes